ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Nutrition and Supplements
Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 13117" data-attributes="member: 3"><p>Adult urology</p><p>Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging &#9734;</p><p>G. Cavallinia, , S. Caracciolob, G. Vitalia, F. Modeninia, G. Biagiottic</p><p></p><p>Abstrac</p><p>Objectives</p><p>To compare testosterone undecanoate versus propionyl-l-carnitine plus acetyl-l-carnitine and placebo in the treatment of male aging symptoms.</p><p></p><p>Methods</p><p>A total of 120 patients were randomized into three groups. The mean patient age was 66 years (range 60 to 74). Group 1 was given testosterone undecanoate 160 mg/day, the second group was given propionyl-l-carnitine 2 g/day plus acetyl-l-carnitine 2 g/day. The third group was given a placebo (starch). Drugs and placebo were given for 6 months. The assessed variables were total prostate-specific antigen, prostate volume, peak systolic velocity, end-diastolic velocity, resistive index of cavernosal penile arteries, nocturnal penile tumescence, total and free testosterone, prolactin, luteinizing hormone, International Index of Erectile Function score, Depression Melancholia Scale score, fatigue scale score, and incidence of side effects. The assessment was performed at intervals before, during, and after therapy.</p><p></p><p>Results</p><p>Testosterone and carnitines significantly improved the peak systolic velocity, end-diastolic velocity, resistive index, nocturnal penile tumescence, International Index of Erectile Function score, Depression Melancholia Scale score, and fatigue scale score. Carnitines proved significantly more active than testosterone in improving nocturnal penile tumescence and International Index of Erectile Function score. Testosterone significantly increased the prostate volume and free and total testosterone levels and significantly lowered serum luteinizing hormone; carnitines did not. No drug significantly modified prostate-specific antigen or prolactin. Carnitines and testosterone proved effective for as long as they were administered, with suspension provoking a reversal to baseline values. Only the group 1 prostate volume proved significantly greater than baseline 6 months after testosterone suspension. Placebo administration proved ineffective. Negligible side effects emerged.</p><p></p><p>Conclusions</p><p>Testosterone and, especially, carnitines proved to be active drugs for the therapy of symptoms associated with male aging.</p><p></p><p>&#9734;</p><p>G. Cavallini and G. Biagiotti are patent inventors for the association of Acetyl-l-Carnitine/Propionyl-l-Carnitine for the therapy of symptoms associated with partial androgen deficiency of the aging male.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 13117, member: 3"] Adult urology Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging ☆ G. Cavallinia, , S. Caracciolob, G. Vitalia, F. Modeninia, G. Biagiottic Abstrac Objectives To compare testosterone undecanoate versus propionyl-l-carnitine plus acetyl-l-carnitine and placebo in the treatment of male aging symptoms. Methods A total of 120 patients were randomized into three groups. The mean patient age was 66 years (range 60 to 74). Group 1 was given testosterone undecanoate 160 mg/day, the second group was given propionyl-l-carnitine 2 g/day plus acetyl-l-carnitine 2 g/day. The third group was given a placebo (starch). Drugs and placebo were given for 6 months. The assessed variables were total prostate-specific antigen, prostate volume, peak systolic velocity, end-diastolic velocity, resistive index of cavernosal penile arteries, nocturnal penile tumescence, total and free testosterone, prolactin, luteinizing hormone, International Index of Erectile Function score, Depression Melancholia Scale score, fatigue scale score, and incidence of side effects. The assessment was performed at intervals before, during, and after therapy. Results Testosterone and carnitines significantly improved the peak systolic velocity, end-diastolic velocity, resistive index, nocturnal penile tumescence, International Index of Erectile Function score, Depression Melancholia Scale score, and fatigue scale score. Carnitines proved significantly more active than testosterone in improving nocturnal penile tumescence and International Index of Erectile Function score. Testosterone significantly increased the prostate volume and free and total testosterone levels and significantly lowered serum luteinizing hormone; carnitines did not. No drug significantly modified prostate-specific antigen or prolactin. Carnitines and testosterone proved effective for as long as they were administered, with suspension provoking a reversal to baseline values. Only the group 1 prostate volume proved significantly greater than baseline 6 months after testosterone suspension. Placebo administration proved ineffective. Negligible side effects emerged. Conclusions Testosterone and, especially, carnitines proved to be active drugs for the therapy of symptoms associated with male aging. ☆ G. Cavallini and G. Biagiotti are patent inventors for the association of Acetyl-l-Carnitine/Propionyl-l-Carnitine for the therapy of symptoms associated with partial androgen deficiency of the aging male. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Nutrition and Supplements
Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top